THE BODY OF EVIDENCE SUPPORTING MESO SCIENCE CONTINUES TO GROW
UC-MSCs may restore oxygenation & downregulate cytokine storm (covid19) without any infusion reaction.
MSC can improve lung microenvironment, pulmonary fibrosis, & lung function and also promote tissue repair & regeneration.
Recent report: 7 patients found that bone marrow MSC therapy was an effective treatment for severe COVID-19 (100% AFFIRMS MESO science). Further, another recent study indicated that bone marrow MSC therapy can improve hypoxia, immune reconstitution, and cytokine storms in patients with severe COVID-19 -- folks, this is why remestemcel-l will be a BLOCKBUSTER.
Link to article:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351637/
Cell Therapy News/Articles, page-5976
-
- There are more pages in this discussion • 11,849 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.053(4.02%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $16.36M | 13.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 35677 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 44262 | 14 |
View Market Depth
| Last trade - 14.03pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |